Le Lézard
Classified in: Science and technology
Subject: OFR

Cellcom Israel Announces Private debenture Offering In Israel

NETANYA, Israel, Nov. 26, 2020 /PRNewswire/ -- Cellcom Israel Ltd. (NYSE: CEL) (TASE: CEL) (hereinafter: the "Company") announced today that following the previously announced preparation for a private debenture offering in Israel of additional debentures of the existing series L debentures, which are listed on the Tel Aviv Stock Exchange, or TASE, the Company  received orders from certain institutional investors for approximately NIS 744 million principal amount of additional Series L debentures, out of which the Company accepted (subject to the TASE's approval) orders for NIS 400 million aggregate principal amount of additional Series L debentures, for a total consideration of approximately NIS 391 million.

The price was set at NIS 977 for each Series L debenture of NIS 1,000 principal amount, reflecting an effective interest of 3.55% per annum. Accordingly, the debentures series L will be issued at a discount over the adjusted principal amount of the debentures (reflecting accumulated interest).

The net proceeds from the offering shall be used for general corporate purposes.

Resale of the new Series L debentures (once issued) shall be subject to the limitations set in section 15c of the Israeli Securities Law and the regulations promulgated thereunder. 

The closing of the private offering is subject to the receipt of the TASE's approval.

For additional details see our most recent annual report for the year ended December 31, 2019 on Form 20-F, filed on March 23, 2020 under: "Item 5. Operating and Financial Review and Prospects ? B. Liquidity and Capital Resources ? Debt Service ? Public Debentures" And our most recent report on Form 6-K filed on November 23, 2020.

The offering described in this press release was made only in Israel and only to residents of Israel. The securities have not been registered under the U.S. Securities Act of 1933 and will not be offered or sold in the United States. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities.

About Cellcom Israel

Cellcom Israel Ltd., established in 1994, is a leading Israeli communications group, providing a wide range of communications services. Cellcom Israel is the largest Israeli cellular provider, providing its cellular subscribers with a broad range of services including cellular telephony, roaming services, text and multimedia messaging, advanced cellular and data services and other value-added services in the areas of  mobile office, data protection etc., based on Cellcom Israel's technologically advanced infrastructure. The Company operates advanced networks enabling high speed broadband and advanced multimedia services. Cellcom Israel offers nationwide customer service including telephone customer service, retail stores, and service and sale centers. Cellcom Israel further provides OTT TV services, internet infrastructure and connectivity services and international calling services, as well as landline telephone services in Israel.  Cellcom Israel's shares are traded both on the New York Stock Exchange (CEL) and the Tel Aviv Stock Exchange (CEL). For additional information please visit the Company's website http://investors.cellcom.co.il.

Company Contact

Shai Amsalem
Chief Financial Officer
Tel: +972-52-998-4774

Investor Relations Contact

Elad Levy
Investor Relations Manager
Tel: +972-52-998-4774


SOURCE Cellcom Israel Ltd.

These press releases may also interest you

at 02:00
Chaser Technologies Limited (Chaser), the global credit control automation platform, today announced the release of a Payment Portal, in app, that enables the customers of users to see all invoices due in one place and pay them instantly. Chaser has...

22 jan 2021
From President Joe Biden's Administration platform, to organizations such as B Corporation, to global enterprises; many have focused their attention to Clean Energy. Studies have already proven that Urban areas account for more than 70% of CO2...

22 jan 2021
Aurinia Pharmaceuticals Inc. ("Aurinia" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has approved LUPKYNISTM (voclosporin) in combination with a background immunosuppressive therapy regimen to treat adult...

22 jan 2021
The building information modeling software market is expected to grow by $ 8.38 bn, decelerate at a CAGR of over 24% during the forecast period. Click & Get Free Sample Report in Minutes The increasing requirements for large-scale project...

22 jan 2021
Lyft, Inc. today urged federal officials to ensure that drive through vaccination sites are accessible to people with mobility challenges. In a letter to the acting administrator of the Centers for Medicare & Medicaid Services, Megan Callahan, Vice...

22 jan 2021
Nagamasa Global, a commodity broker that aims to offer the highest level of customer service and transaction capability required by today's sophisticated financial market participants, today announced support of over 400 technology devices throughout...

News published on 26 november 2020 at 01:51 and distributed by: